Skip to main content
. 2018 Oct 10;5(11):1338–1349. doi: 10.1002/acn3.651

Figure 3.

Figure 3

Study flow. Disposition of patients in the repeated‐dose period included in PK evaluation. PK, pharmacokinetics.